These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23944368)

  • 61. Expression of biologically active mouse and human CD95/APO-1/Fas ligand in the baculovirus system.
    Mariani SM; Matiba B; Sparna T; Krammer PH
    J Immunol Methods; 1996 Jun; 193(1):63-70. PubMed ID: 8690931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Functional role of CD95 ligand in concanavalin A-induced intestinal intraepithelial lymphocyte cytotoxicity.
    Ghoreschi K; Muders M; Enders GA
    Immunology; 1998 Dec; 95(4):566-71. PubMed ID: 9893046
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.
    Tan L; Zhang C; Dematos J; Kuang L; Jung JU; Liang X
    J Virol; 2016 Nov; 90(21):9782-9796. PubMed ID: 27558422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
    Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
    J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Redistribution of CD95 into the lipid rafts to treat cancer cells?
    Segui B; Legembre P
    Recent Pat Anticancer Drug Discov; 2010 Jan; 5(1):22-8. PubMed ID: 19663773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice.
    Poissonnier A; Sanséau D; Le Gallo M; Malleter M; Levoin N; Viel R; Morere L; Penna A; Blanco P; Dupuy A; Poizeau F; Fautrel A; Seneschal J; Jouan F; Ritz J; Forcade E; Rioux N; Contin-Bordes C; Ducret T; Vacher AM; Barrow PA; Flynn RJ; Vacher P; Legembre P
    Immunity; 2016 Jul; 45(1):209-23. PubMed ID: 27438772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cloak and dagger in the avoidance of immune surveillance.
    Pinkoski MJ; Green DR
    Curr Opin Genet Dev; 2000 Feb; 10(1):114-9. PubMed ID: 10679393
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
    Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
    Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
    J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
    Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
    AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo.
    Aragane Y; Maeda A; Cui CY; Tezuka T; Kaneda Y; Schwarz T
    J Invest Dermatol; 2000 Dec; 115(6):1008-14. PubMed ID: 11121134
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting the Fas/Fas ligand pathway in cancer.
    O'Brien DI; Nally K; Kelly RG; O'Connor TM; Shanahan F; O'Connell J
    Expert Opin Ther Targets; 2005 Oct; 9(5):1031-44. PubMed ID: 16185156
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.
    Weiss EM; Schmidt A; Vobis D; Garbi N; Lahl K; Mayer CT; Sparwasser T; Ludwig A; Suri-Payer E; Oberle N; Krammer PH
    J Immunol; 2011 Aug; 187(4):1684-91. PubMed ID: 21746966
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS.
    Kantarci OH; Hebrink DD; Achenbach SJ; Atkinson EJ; de Andrade M; McMurray CT; Weinshenker BG
    J Neuroimmunol; 2004 Jan; 146(1-2):162-70. PubMed ID: 14698859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation.
    Nijkamp MW; Hoogwater FJ; Steller EJ; Westendorp BF; van der Meulen TA; Leenders MW; Borel Rinkes IH; Kranenburg O
    J Hepatol; 2010 Dec; 53(6):1069-77. PubMed ID: 20832890
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of CD95 ligand in melanocytic lesions as a diagnostic marker.
    Maeda A; Aragane Y; Tezuka T
    Br J Dermatol; 1998 Aug; 139(2):198-206. PubMed ID: 9767232
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characterization of daunorubicin-induced apoptosis in retinal pigment epithelial cells: modulation by CD95L.
    Hueber A; Weller M; Welsandt G; Kociok N; Kirchhof B; Esser P
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2851-7. PubMed ID: 12824222
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of CD95-mediated signaling by post-translational modifications: towards understanding CD95 signaling networks.
    Seyrek K; Lavrik IN
    Apoptosis; 2019 Jun; 24(5-6):385-394. PubMed ID: 31069559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.